ResearcherMayo ClinicNo recent work listed

Amanda Saravia-Butler

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7505-2743; OpenAlex author ID A5001481592. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper

Papers 2

A small molecule inhibitor of atypical protein kinase C signaling inhibits pancreatic cancer cell transformed growth and invasion. Co-author DOI 10.18632/oncotarget.3812 ↗
Protein kinase C zeta regulates human pancreatic cancer cell transformed growth and invasion through a STAT3-dependent mechanism. Co-author DOI 10.1371/journal.pone.0072061 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Nicole R Murray · 2 shared papers, 2013–2015 · strength 0.10
- Paper A small molecule inhibitor of atypical protein kinase C signaling inhibits pancreatic cancer cell transformed growth an… DOI 10.18632/oncotarget.3812 ↗
- Paper Protein kinase C zeta regulates human pancreatic cancer cell transformed growth and invasion through a STAT3-dependent … DOI 10.1371/journal.pone.0072061 ↗
Kristin S. Inman · 1 shared paper, 2015 · strength 0.06
- Paper A small molecule inhibitor of atypical protein kinase C signaling inhibits pancreatic cancer cell transformed growth an… DOI 10.18632/oncotarget.3812 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.